HealthLinc Providing Pediatric COVID-19 Vaccinations to Children Ages 5-11
HealthLinc has started providing COVID-19 vaccinations to children ages 5-11. Earlier this month, the Center for Disease Control (CDC) granted approval of the Pfizer pediatric COVID-19 vaccine. The vaccine is one-third of the dose given to adolescents, teens and adults and is given in a two-dose series, three weeks apart. Over six million children in the United States have tested positive for coronavirus, 20,000 have been hospitalized and 500 have died, according to the most recent data from American Academy of Pediatrics. “This is a big step in our efforts to stop COVID-19,” states Beth Wrobel, HealthLinc CEO.
